Portal de Periódicos da CAPES

Three-Dimensional Tissue Models for Drug Discovery and Toxicology

2009; Bentham Science Publishers; Volume: 3; Issue: 2 Linguagem: Inglês

10.2174/187220809788700201

2212-4012

Francesco Pampaloni, Ernst H. K. Stelzer, Andrea Masotti,

Viral Infectious Diseases and Gene Expression in Insects

Launching a new drug on the market is an extremely time-consuming and expensive process. The total costs from the lab bench to the patient's bedside are in the range of $800 million for each new compound. Innovative pre-clinical assays are urgently needed to select the most promising drug candidates. High-throughput molecular screening does not provide information on the effects on cellular functions. Testing on animals is expensive, ethically controversial, and poorly predictive of the response in humans. Conventional two-dimensional (2D) cellular assays do not accurately reflect the drug response in vivo. To overcome these limitations, biotechnologists are developing three-dimensional (3D) cultures. 3D cultures provide more accurate compound screening and can eliminate toxic and ineffective substances at an early stage. Moreover, 3D cultures can accomplish the 3R agenda (refinement, reduction, and replacement) for the replacement of toxicity testing on animals. We provide an up-to-date overview on the patents in the field.